Trial intelligence / Profile preview

MENOPUR versus recombinant FSH in controlled ovarian stimulation with GnRH antagonist and single embryo transfer

2008-006775-67Phase 3Completed

Sponsor
Ferring Pharmaceuticals
Start
Mar 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, open-label trial in infertility comparing MENOPUR with Recombinant FSH (2 arms). Primary endpoint: Ongoing pregnancy rate after one fresh embryo replacement cycle. Started Mar 2009; status: completed.

02

Drugs

menotropinsrecombinant human follicle stimulating hormone
03

Conditions

infertility

Beyond the preview

Go deeper on 2008-006775-67.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006775-67.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call